Completed
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
NCT01560793
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Miami Research Associates Miami, Florida, United States
- Johnson County Clin-Trials Lenexa, Kansas, United States